Horizon Discovery Share Discussion Threads

[soundbuy] 17/4/2020 12:42

'the announcement didn't say at what price the shares would be placed'


Correct - have a gander

[bouleversee] 17/4/2020 12:29

Unless I missed it, the announcement didn't say at what price the shares would be placed. I always think it is rather unfair that existing ordinary shareholders, who sill suffer from some dilution, whereas I think directors can participate. I wonder if and when we will ever get our money back let alone any return on it.

[soundbuy] 17/4/2020 12:02

Placing ahoy.......4.5%...

Hopefully taken as a positive.....but that will down to the bookbuild.....

[rambutan2] 14/4/2020 21:59

...Horizon is already a key supplier for research relating to COVID-19, providing many tools and services to academia and industry to support their efforts in addressing the pandemic. This offering further extends Horizon’s COVID-19 support portfolio: hxxps://horizondiscovery.com/en/products/covid19-research-support

Jesús Zurdo, Global Head Bioprocessing, Horizon Discovery said: “The current coronavirus crisis is highlighting existing shortcomings in the development of much-needed therapeutics. Horizon Discovery is fully committed to help innovators in their efforts to develop new solutions to tackle the COVID-19 pandemic. We are providing immediate access to our state-of-the-art bioproduction platform under very favorable terms to facilitate such efforts.”

Terry Pizzie, CEO, Horizon Discovery said: “We are committed to providing flexible, royalty-free access licensing terms and solutions that streamline development and production processes. Building upon more than a decade of experience in cell line engineering, we developed our CHOSOURCE cell line and now support a growing number of pharmaceutical companies in bioproduction. We are doing all that we can to support the fight against COVID-19 and hope that offering rapid access to our CHOSOURCE platform will help to accelerate the development and validation of new therapies to combat the pandemic.”

[kestelmill] 12/4/2020 09:26

Love the optimism, but can someone explain how HZD reagents can be applied to Covid19. Maybe therapeutics - identifying key genes involved - but not IVD testing. The co update didnt sound like this is a Covid19 slam dunk

[mamcw] 12/4/2020 09:04

Thanks. From what I've read, a shortage of reagents is one of the main barriers to effective testing for Covid-19. So maybe there is an angle for HZD here. The press article refers to a Cambridge-based company in addition to the two majors.

[bobdouthwaite] 12/4/2020 08:39

From the HZD website, dated 3 April: “In terms of Covid-related activity it’s a very different take: we are engaging with some institutions in the US and we may be able to provide reagents to them. Of course, we don’t always know if they’re testing for Covid-19 but there are various institutions and government bodies where we can be of use.”

AstraZeneca is of course "a Cambridge based company".

[mamcw] 12/4/2020 08:27

According to Alliance news, GSK, AstraZeneca and a Cambridge based company are working together to deliver a validated Covid-19 antibody test by the beginning of May. Anyone know if this Cambridge-based company is by chance HZD, as it has good links with both of these majors?

[the stigologist] 07/4/2020 06:43

Woodford is due to make a come back soon

Clever money is buying his old favourites

'Criminals always return to the scene of their crimes'

[edwards9] 07/4/2020 06:10

Any selling now won't be from Woodford, he was out last year.

Confirmed by CEO during HY 2019 webcast presentation Q&A made in September 2019.

[srichardson8] 06/4/2020 13:04

It might be of interest to recall that in 2017 Woodford and Invesco (Perpetual) held an aggregate of 33% of HZD stock at the peak. Most of the Woodford stake was taken by Value Act (20.9% holder). The company website shows neither are now significant (that os over 3%) holders. Bottom of the list at #9 is the new shareholder Platinum at 3% (4.5mn shares of the 150mn in issue). I wanted to check this as I see the Perpetual Income & Growth Trust Trust is seeking a new manager after a pretty dire performance under Perpetual management over the past five years. Danaher is the third largest after Value Act and Canaccord.

[srichardson8] 04/4/2020 19:29

There was exceptionally large volume in HXD yesterday, over 1mn shares, mostly in a few block trades 'off market'. One could speculate that this may be further selling from the rump of the Neil Woodford holding, or possibly from his former acolyte at Invesco who was already under redemption pressure prior to the general market collapse. I suppose the point, in the short term anyway, is that another institution is prepared to pick up a reasonably large size line at around the current price and this is mildly encouraging. Over the past three months Horizon has pretty much behaved in line with the market, no better no worse. The most recent company statement outlined the delay to publication of the annual figuers (to Dec 2019)and suggested that the company is still able to trade in the current climate and has an 'OK'cash position. Personally I have kept my position intact as I still believe that it is well-positioned as a supplier to the gene editing market but I accept that it is a pretty high risk investment.
The stock market is hugely volatile and highly unpredictable at the moment. None of us have seen the like. 'Experts' have been giving advice freely but we are all basically hoping that there is some breakthrough on the c-19 front before long and we can start to return to a normal social and economic life. At some stage you are quite right to suggest that there must be a reckoning, including changes to the tax code, but it will presumably take some years before the ship is righted. It would be foolish of me to give any advice beyond saying that as far as possible keep to what you are comfortable with, do not risk investments that you cannot afford to lose. Sorry not to be more useful and good luck.

[bouleversee] 03/4/2020 16:41

So that shouldn't reflect on HZD one way or another. Just a tidy up operation between the other 2 companies.

I wonder why HZD's share price has shot up today but I haven't checked to see whether the index has also done so.

What do you think about their prospects going forward? I'm losing rather a lot on my holding and wondering whether to use the spare cash I have in my ISA to top up, or whether Next, RDSB, SMT, or Photo-Me would be a better bet. or whether none of them is worth topping up. Am losing on all but SMT and the rest of that ISA is a car crash and I wouldn't think of adding. HZD has the (very relevant to me)AIM IHT exemption at present, but for how much longer? And I wonder how long ISAs will survive. The chancellor is going to need to extract as much tax as possible.

[srichardson8] 03/4/2020 15:52

Danaher bought the biopharma division of GE Healthcare last year but the transaction was not completed until this past week when certain disposals were made to meet EU regulations. The cost to Danaher was reportedly $20bn. GE Healthcare had an 8.67% stake in HZD which has now transferred to Danaher. Danaher is a very large corporation with a market capitalisation of $95bn (at the current price of around $135), 20 major operating companies and most recent annual sales of $18bn. Its biggest division is medical equipment which includes Beckman Coulter a diagnostic specialist currently getting some attention as it is trying to develop a Covid-19 antibody test kit. What happens to the HZD stake is anyone's guess.
Or so I understand. Corrections or amplification welcome.

[bouleversee] 03/4/2020 12:50

So does that mean HZD now owns those shares or have they been cancelled. Apols. for being a bit thick. Can't quite get my head round the mechanics.

[rambutan2] 03/4/2020 12:29

No!

See my post above.

[mamcw] 03/4/2020 12:23

So GE Healthcare's stake of 8.67% has been placed out according to the latest RNS?

[bouleversee] 02/4/2020 21:43

So why the heck are they bombing?

[espiral59] 02/4/2020 21:17

Many researchers and collaborators are contacting Horizon for custom RNA and other tools for #COVID19 detection assay development and #SARSCoV2 research. Take a look at the tools that we have available here:https://t.co/7n0DBlypVc

[kestelmill] 01/4/2020 15:44

Every time someone wanted in, it also means someone else wanted out!

[rambutan2] 01/4/2020 15:39

gunmartin, I think those must be shares inherited from GE following HZD's acquisition of Dharmacon from GE. Sorry am a bit pushed for time...

[gnnmartin] 01/4/2020 12:47

Another big bet on HZD today (Danaher Innovation Center LLC, USA, reveal a holding of 8.67%). HZD are slap in the middle of the hottest area of biochemistry, but I'm just not sure how they are going to make money from it. I have a small holding, held for my daughter.